Your SlideShare is downloading. ×
0
Zytiga Shown to Reduce Pain in Combination Therapy
Zytiga Shown to Reduce Pain in Combination Therapy
Zytiga Shown to Reduce Pain in Combination Therapy
Zytiga Shown to Reduce Pain in Combination Therapy
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Zytiga Shown to Reduce Pain in Combination Therapy

115

Published on

In a recent study led by scientists in the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center, a combination of Zytiga and the drug prednisone …

In a recent study led by scientists in the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center, a combination of Zytiga and the drug prednisone was shown to slow down pain progression in men with advanced prostate cancer.

Published in: Devices & Hardware
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
115
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Zytiga Shown to Reduce Pain in Combination Therapy By: Dr. Lindsay Rosenwald
  • 2. Introduction  As a co-founder of Cougar Biotechnology, Inc., Dr. Lindsay Rosenwald helped to spearhead the development of a drug now marketed as Zytiga.  Dr. Lindsay Rosenwald also assisted in the development of the cancer-fighting drug arsenic trioxide.
  • 3. About the Study  In a recent study led by scientists in the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center, a combination of Zytiga and the drug prednisone was shown to slow down pain progression in men with advanced prostate cancer.  The finding was important in preserving the quality of life for those patients, as pain sometimes proves an effective predictor of survival.
  • 4. Results  The study included 1,088 men with metastatic-castrationresistant prostate cancer that had already spread elsewhere in their bodies.  Pain progression took eight months longer on average for men who took Zytiga and prednisone.  Additionally, more time elapsed before the pain interfered with their daily activities and impacted their quality of life.

×